Corrigendum: High expression of PARP1 in tumor and stroma cells predicts prognosis and platinum resistance in patients with advanced epithelial ovarian cancer

Affiliations

Wei-Wei Zuo: Department of Gynecology, Fourth Hospital, Hebei Medical University, Shijiazhuang, China
Wei-Wei Zuo: Department of Gynecology, Tangshan People’s Hospital, Tangshan, China
Chun-Fang Zhao: Department of Histoplasty and Embryology, Hebei Medical University, Shijiazhuang, China
Yan Li: Department of Molecular Biology, Fourth Hospital, Hebei Medical University, Shijiazhuang, China
Hai-Yan Sun: Department of Gynecology, Fourth Hospital, Hebei Medical University, Shijiazhuang, China
Guo-Ming Ma: Department of gastrointestinal surgery, Tangshan People’s Hospital, Tangshan, China
Yue-Ping Liu: Department of Pathology, Hebei Medical University, Fourth Hospital, Shijiazhuang, China
Shan Kang: Department of Gynecology, Fourth Hospital, Hebei Medical University, Shijiazhuang, China

Abstract

No abstracts available.

ISSN: 2234-943X (Online)
Publisher: Frontiers Media S.A.
Country of publisher: Switzerland
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://www.frontiersin.org/journals/oncology/